Using gene sequencing techniques, researchers clone factor VIII
The successful cloning of the factor VIII gene in 1984 was a major breakthrough, allowing production of recombinant human factor VIII (r factor VIII). Clinical trials in humans began three years later, and this was truly an exciting time, especially for families who had lost loved ones to AIDS.
By 1992, two pharmaceutical companies had licensed r factor VIII products for use in hemophilia A.
